J&J's HIV vaccine fails in sub-Saharan Africa trial
Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday.
Aug 31, 2021
0
127